Genetically engineered cell lines
Our CRISPR/Cas9 gene-editing platform is optimized for customized cell line development .
A major benefit for you and your research is our rigorous procedure to quickly assess the feasibility of using your own cell line, and adapt our process to your cell line's specifics, if need be. Genetic modifications designed and performed with our standards in your favorite cell line optimize the use of your existing data and avoid the need for new standardization experiments.
Our state-of-the-art knowledge of the technologies we use, combined with thorough design assessment and optimized proprietary protocols, allow us to ensure reliable and reproducible performance in a wide range of rodent or human cell lines, including tumor cell lines for syngeneic models and hard-to-edit suspension cells:
- Breast cancer, colorectal cancer, melanoma, insulinoma, and glioblastoma cell lines such as MC38, CT26, 4T1, B16F10, GL261 mouse lines
- B-cell lymphoma, macrophage, and leukemia cell lines, including HBL1 and VL51 human cell lines
- Embryonic stem cells, induced pluripotent stem cells, neural stem cells, and more
Along with its expertise, we provide our customers with FTO, the freedom to operate on key technologies, including CRISPR/Cas9.
